Loading…

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas

The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma...

Full description

Saved in:
Bibliographic Details
Published in:Acta neuropathologica communications 2021-08, Vol.9 (1), p.142-142, Article 142
Main Authors: Wei, Xin, Meel, Michaël H, Breur, Marjolein, Bugiani, Marianna, Hulleman, Esther, Phoenix, Timothy N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43
cites cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43
container_end_page 142
container_issue 1
container_start_page 142
container_title Acta neuropathologica communications
container_volume 9
creator Wei, Xin
Meel, Michaël H
Breur, Marjolein
Bugiani, Marianna
Hulleman, Esther
Phoenix, Timothy N
description The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.
doi_str_mv 10.1186/s40478-021-01243-1
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A673028865</galeid><doaj_id>oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4</doaj_id><sourcerecordid>A673028865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</originalsourceid><addsrcrecordid>eNptkk1rHSEUhofS0oQ0f6CLMlAo3Uzq5-hsCiH9CgS6adfi1eOMlxlN1Qnk39ebm6b3lurCgz7vKx7fpnmN0QXGsv-QGWJCdojgDmHCaIefNacEcdzxoUfPD-qT5jznLapjwJhK-bI5oYwRPiBx2thP4HzwYWzLusTU6Zyj8bqAbe90NuusUztBgRRHCODLfetDewu2IsmbdvLj1I1JW2h1sK31zq0Z2sXb2Qdox9nHRedXzQun5wznj-tZ8_PL5x9X37qb71-vry5vOsMHVjrBLRGcCOl6zgm2hHM3ONlzPQAnhHK6YUgMRteCO-awsP1GgkMSg-aG0bPmeu9ro96q2-QXne5V1F49bMQ0Kp2KNzMoLoQRegOUUc2ooUMvcD9wzHpdjd3O6-Pe63bdLGANhJL0fGR6fBL8pMZ4pySVmHNRDd4_GqT4a4Vc1OKzgXnWAeKaFeE9w5Rhwiv69h90G9cUaqsqJRiTgxTiLzXq-gAfXKz3mp2puuwFRUTWVlXq4j9UnRYWb2Ko3133jwTvDgQT6LlMOc5r8THkY5DsQZNizgncUzMwUrtMqn0mVc2kesikwlX05rCNT5I_CaS_AS9_2hE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2574489877</pqid></control><display><type>article</type><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</creator><creatorcontrib>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</creatorcontrib><description>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</description><identifier>ISSN: 2051-5960</identifier><identifier>EISSN: 2051-5960</identifier><identifier>DOI: 10.1186/s40478-021-01243-1</identifier><identifier>PMID: 34425907</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Animals ; Antibodies ; Blood brain barrier ; Blood-Brain Barrier - pathology ; Brain - blood supply ; Brain - pathology ; Brain cancer ; Brain Neoplasms - pathology ; Brain tumors ; Child ; Diffuse intrinsic pontine glioma ; Diffuse midline glioma ; Endothelial cells ; Glioma ; Glioma - pathology ; Gliomas ; Histology ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Mutation ; Neoplasm Grading - methods ; Neurovascular Coupling - physiology ; Neurovascular unit ; Pediatric high-grade glioma ; Pediatrics ; Plasmids ; Tumors ; Xenograft Model Antitumor Assays - methods</subject><ispartof>Acta neuropathologica communications, 2021-08, Vol.9 (1), p.142-142, Article 142</ispartof><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</citedby><cites>FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</cites><orcidid>0000-0003-4771-4003</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381557/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2574489877?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34425907$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Xin</creatorcontrib><creatorcontrib>Meel, Michaël H</creatorcontrib><creatorcontrib>Breur, Marjolein</creatorcontrib><creatorcontrib>Bugiani, Marianna</creatorcontrib><creatorcontrib>Hulleman, Esther</creatorcontrib><creatorcontrib>Phoenix, Timothy N</creatorcontrib><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><title>Acta neuropathologica communications</title><addtitle>Acta Neuropathol Commun</addtitle><description>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Blood brain barrier</subject><subject>Blood-Brain Barrier - pathology</subject><subject>Brain - blood supply</subject><subject>Brain - pathology</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain tumors</subject><subject>Child</subject><subject>Diffuse intrinsic pontine glioma</subject><subject>Diffuse midline glioma</subject><subject>Endothelial cells</subject><subject>Glioma</subject><subject>Glioma - pathology</subject><subject>Gliomas</subject><subject>Histology</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Mutation</subject><subject>Neoplasm Grading - methods</subject><subject>Neurovascular Coupling - physiology</subject><subject>Neurovascular unit</subject><subject>Pediatric high-grade glioma</subject><subject>Pediatrics</subject><subject>Plasmids</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays - methods</subject><issn>2051-5960</issn><issn>2051-5960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1rHSEUhofS0oQ0f6CLMlAo3Uzq5-hsCiH9CgS6adfi1eOMlxlN1Qnk39ebm6b3lurCgz7vKx7fpnmN0QXGsv-QGWJCdojgDmHCaIefNacEcdzxoUfPD-qT5jznLapjwJhK-bI5oYwRPiBx2thP4HzwYWzLusTU6Zyj8bqAbe90NuusUztBgRRHCODLfetDewu2IsmbdvLj1I1JW2h1sK31zq0Z2sXb2Qdox9nHRedXzQun5wznj-tZ8_PL5x9X37qb71-vry5vOsMHVjrBLRGcCOl6zgm2hHM3ONlzPQAnhHK6YUgMRteCO-awsP1GgkMSg-aG0bPmeu9ro96q2-QXne5V1F49bMQ0Kp2KNzMoLoQRegOUUc2ooUMvcD9wzHpdjd3O6-Pe63bdLGANhJL0fGR6fBL8pMZ4pySVmHNRDd4_GqT4a4Vc1OKzgXnWAeKaFeE9w5Rhwiv69h90G9cUaqsqJRiTgxTiLzXq-gAfXKz3mp2puuwFRUTWVlXq4j9UnRYWb2Ko3133jwTvDgQT6LlMOc5r8THkY5DsQZNizgncUzMwUrtMqn0mVc2kesikwlX05rCNT5I_CaS_AS9_2hE</recordid><startdate>20210823</startdate><enddate>20210823</enddate><creator>Wei, Xin</creator><creator>Meel, Michaël H</creator><creator>Breur, Marjolein</creator><creator>Bugiani, Marianna</creator><creator>Hulleman, Esther</creator><creator>Phoenix, Timothy N</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4771-4003</orcidid></search><sort><creationdate>20210823</creationdate><title>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</title><author>Wei, Xin ; Meel, Michaël H ; Breur, Marjolein ; Bugiani, Marianna ; Hulleman, Esther ; Phoenix, Timothy N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Blood brain barrier</topic><topic>Blood-Brain Barrier - pathology</topic><topic>Brain - blood supply</topic><topic>Brain - pathology</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain tumors</topic><topic>Child</topic><topic>Diffuse intrinsic pontine glioma</topic><topic>Diffuse midline glioma</topic><topic>Endothelial cells</topic><topic>Glioma</topic><topic>Glioma - pathology</topic><topic>Gliomas</topic><topic>Histology</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Mutation</topic><topic>Neoplasm Grading - methods</topic><topic>Neurovascular Coupling - physiology</topic><topic>Neurovascular unit</topic><topic>Pediatric high-grade glioma</topic><topic>Pediatrics</topic><topic>Plasmids</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wei, Xin</creatorcontrib><creatorcontrib>Meel, Michaël H</creatorcontrib><creatorcontrib>Breur, Marjolein</creatorcontrib><creatorcontrib>Bugiani, Marianna</creatorcontrib><creatorcontrib>Hulleman, Esther</creatorcontrib><creatorcontrib>Phoenix, Timothy N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Acta neuropathologica communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Xin</au><au>Meel, Michaël H</au><au>Breur, Marjolein</au><au>Bugiani, Marianna</au><au>Hulleman, Esther</au><au>Phoenix, Timothy N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas</atitle><jtitle>Acta neuropathologica communications</jtitle><addtitle>Acta Neuropathol Commun</addtitle><date>2021-08-23</date><risdate>2021</risdate><volume>9</volume><issue>1</issue><spage>142</spage><epage>142</epage><pages>142-142</pages><artnum>142</artnum><issn>2051-5960</issn><eissn>2051-5960</eissn><abstract>The blood-brain barrier (BBB) plays important roles in brain tumor pathogenesis and treatment response, yet our understanding of its function and heterogeneity within or across brain tumor types remains poorly characterized. Here we analyze the neurovascular unit (NVU) of pediatric high-grade glioma (pHGG) and diffuse midline glioma (DMG) using patient derived xenografts and natively forming glioma mouse models. We show tumor-associated vascular differences between these glioma subtypes, and parallels between PDX and mouse model systems, with DMG models maintaining a more normal vascular architecture, BBB function and endothelial transcriptional program relative to pHGG models. Unlike prior work in angiogenic brain tumors, we find that expression of secreted Wnt antagonists do not alter the tumor-associated vascular phenotype in DMG tumor models. Together, these findings highlight vascular heterogeneity between pHGG and DMG and differences in their response to alterations in developmental BBB signals that may participate in driving these pathological differences.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>34425907</pmid><doi>10.1186/s40478-021-01243-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4771-4003</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2051-5960
ispartof Acta neuropathologica communications, 2021-08, Vol.9 (1), p.142-142, Article 142
issn 2051-5960
2051-5960
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_577c7abe343a43c39671695146a4f1f4
source Publicly Available Content Database; PubMed Central
subjects Animals
Antibodies
Blood brain barrier
Blood-Brain Barrier - pathology
Brain - blood supply
Brain - pathology
Brain cancer
Brain Neoplasms - pathology
Brain tumors
Child
Diffuse intrinsic pontine glioma
Diffuse midline glioma
Endothelial cells
Glioma
Glioma - pathology
Gliomas
Histology
Humans
Mice
Mice, Inbred NOD
Mice, SCID
Mutation
Neoplasm Grading - methods
Neurovascular Coupling - physiology
Neurovascular unit
Pediatric high-grade glioma
Pediatrics
Plasmids
Tumors
Xenograft Model Antitumor Assays - methods
title Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20tumor-associated%20vascular%20heterogeneity%20in%20pediatric%20high-grade%20and%20diffuse%20midline%20gliomas&rft.jtitle=Acta%20neuropathologica%20communications&rft.au=Wei,%20Xin&rft.date=2021-08-23&rft.volume=9&rft.issue=1&rft.spage=142&rft.epage=142&rft.pages=142-142&rft.artnum=142&rft.issn=2051-5960&rft.eissn=2051-5960&rft_id=info:doi/10.1186/s40478-021-01243-1&rft_dat=%3Cgale_doaj_%3EA673028865%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c594t-75d275278f65521d255f9f865a9e522353b4079ca53b5f4f17d6b8ef081ea5c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2574489877&rft_id=info:pmid/34425907&rft_galeid=A673028865&rfr_iscdi=true